$3MINDIA 📊 Q1 FY26 Financial Snapshot Net Profit: ₹2.33B vs ₹1.78B (YoY +31%). EBITDA: ₹2.38B vs ₹2.4B (YoY slight decline). EBITDA Margin: 16.73% vs 20.21% (YoY margin compression). 📌 Fundamentals & Ratios Debt-to-Equity: ~0.1, very low leverage, strong balance sheet. P/E Ratio: ~40–42, premium valuation reflecting brand strength. ROE: ~18–19%, strong capital efficiency. EBITDA Margin: 16.73%, lower YoY due to rising input costs. Dividend Yield: ~0.7%, consistent payout. 🏭 Key Projects & Business Drivers Healthcare & Safety: Expansion in medical supplies and protective equipment. Industrial Solutions: Growth in adhesives, abrasives, and filtration systems. Consumer Products: Strong demand for home care and office supplies. Innovation: R&D focus on sustainability and advanced materials. Digital Integration: Leveraging automation and smart manufacturing. ⚠️ Risks & Watchpoints Margin Pressure: Input cost inflation impacting profitability. Competition: Intense rivalry in industrial and consumer segments. Regulatory Risks: Compliance with environmental and safety standards. Global Demand Cyclicality: Exposure to industrial and consumer cycles. Execution Risks: Scaling innovation projects efficiently.

#FundamentalViews#Miscellaneous#MacroViews#PersonalFinance#EquityResearch

870 likes·54 comments